Monoclonal gammopathy of undetermined significance other diagnostic studies

Jump to navigation Jump to search

Monoclonal gammopathy of undetermined significance Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Monoclonal gammopathy of undetermined significance from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Monoclonal gammopathy of undetermined significance other diagnostic studies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Monoclonal gammopathy of undetermined significance other diagnostic studies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Monoclonal gammopathy of undetermined significance other diagnostic studies

on Monoclonal gammopathy of undetermined significance other diagnostic studies

Monoclonal gammopathy of undetermined significance other diagnostic studies in the news

Blogs on Monoclonal gammopathy of undetermined significance other diagnostic studies

Directions to Hospitals Treating Monoclonal gammopathy of undetermined significance

Risk calculators and risk factors for Monoclonal gammopathy of undetermined significance other diagnostic studies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omer Kamal, M.D.[2]

Overview

The protein electrophoresis test should be repeated annually, and if there is any concern for a rise in the level of monoclonal protein, then prompt referral to a haematologist is required. A bone marrow biopsy should be performed.

Other Diagnostic Studies

Protein Electrophoresis

The protein electrophoresis test should be repeated annually, and if there is any concern for a rise in the level of monoclonal protein, then prompt referral to a haematologist is required.[1][2]

Bone Marrow Biopsy

A bone marrow biopsy should be performed because a diagnosis of MGUS requires the presence of less than 10% clonal plasma cells.[1][2]

References

  1. 1.0 1.1 Jang ST, Sohn IS, Jin ES, Cho JM, Kim CJ, Lim SJ (April 2009). "A case of cardiac dysfunction associated with monoclonal gammopathy of undetermined significance". J. Korean Med. Sci. 24 (2): 354–6. doi:10.3346/jkms.2009.24.2.354. PMC 2672144. PMID 19399286.
  2. 2.0 2.1 Mangiacavalli S, Cocito F, Pochintesta L, Pascutto C, Ferretti V, Varettoni M, Zappasodi P, Pompa A, Landini B, Cazzola M, Corso A (October 2013). "Monoclonal gammopathy of undetermined significance: a new proposal of workup". Eur. J. Haematol. 91 (4): 356–60. doi:10.1111/ejh.12172. PMID 23859528.

Template:WH Template:WS